Cargando…

Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations

BACKGROUND: Ambroxol relieves cough symptoms based on its secretagogue, anti-inflammatory, anti-oxidant, anti-bacterial, anti-viral, immunomodulatory and local anesthetic effects. The present study was designed to explore differential patient profiles and efficacy against acute respiratory symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kardos, Peter, Beeh, Kai-Michael, Sent, Ulrike, Mueck, Tobias, Gräter, Heidemarie, Michel, Martin C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030777/ https://www.ncbi.nlm.nih.gov/pubmed/29973292 http://dx.doi.org/10.1186/s40360-018-0229-y

Ejemplares similares

Factors associated with efficacy of an ibuprofen/pseudoephedrine combination drug in pharmacy customers with common cold symptoms
por: Klimek, Ludger, et al.
Publicado: (2016)

Impact of guideline awareness on the counseling of patients with acute cough among general practitioners and pharmacy personnel
por: Kardos, Peter, et al.
Publicado: (2021)

Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan(®) Retard) Compared with Other Formulations in Healthy Volunteers
por: Ollier, Celine, et al.
Publicado: (2020)

An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children
por: Kantar, Ahmad, et al.
Publicado: (2020)

Results from a pharmacy-based patient survey on the use of a fixed combination analgesic containing acetylsalicylic acid, paracetamol and caffeine by self-diagnosing and self-treating patients
por: Gaul, Charly, et al.
Publicado: (2016)

Ambroxol for the treatment of fibromyalgia: science or fiction?
por: Kern, Kai-Uwe, et al.
Publicado: (2017)

Impact of the Neck and/or Shoulder Pain on Self-reported Headache Treatment Responses – Results From a Pharmacy-Based Patient Survey
por: Gaul, Charly, et al.
Publicado: (2022)

Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsy
por: Kim, Yoon-Myung, et al.
Publicado: (2020)

Influence of Pharmacy Characteristics and Customer Quality of Life on Satisfaction of Community Pharmacy Customers
por: Al-Jumaili, Ali Azeez, et al.
Publicado: (2020)

Value of ambroxol in the treatment of asthmatic bronchitis
por: Du, Xiaoxia, et al.
Publicado: (2020)

Polypharmacology of ambroxol in the treatment of COVID-19
por: Wang, Ziyuan, et al.
Publicado: (2023)

Use of Ambroxol as Therapy for Gaucher Disease
por: Zhan, Xia, et al.
Publicado: (2023)

Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
por: Bendikov-Bar, Inna, et al.
Publicado: (2013)

Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation
por: Takeda, Katsuyuki, et al.
Publicado: (2016)

Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis
por: Chenot, Jean-François, et al.
Publicado: (2014)

Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016)

Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice
por: Braun, Lesley A, et al.
Publicado: (2010)

Ambroxol: utilidad en la enfermedad de menbrana hiliana
por: Reyes Salazar, Gonzálo
Publicado: (1995)

Preparation and Evaluation of Microencapsulated Fast Melt Tablets of Ambroxol Hydrochloride
por: Jacob, S., et al.
Publicado: (2009)

The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats
por: Gao, Xiwen, et al.
Publicado: (2011)

Simultaneous UV Spectrophotometric Estimation of Ambroxol Hydrochloride and Levocetirizine Dihydrochloride
por: Prabhu, S. Lakshmana, et al.
Publicado: (2008)

Enhanced Controlled Transdermal Delivery of Ambroxol from the EVA Matrix
por: Cho, C. W., et al.
Publicado: (2012)

Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2
por: Alkotaji, Myasar
Publicado: (2020)

Ambroxol Treatment Suppresses the Proliferation of Chlamydia pneumoniae in Murine Lungs
por: Kókai, Dávid, et al.
Publicado: (2021)

Does Ambroxol alleviate kidney ischemia-reperfusion injury in rats?
por: Gültekin, Çağrı, et al.
Publicado: (2022)

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
por: McNeill, Alisdair, et al.
Publicado: (2014)

Factors affecting pharmacy engagement and pharmacy customer devotion in community pharmacy: A structural equation modeling approach
por: Nitadpakorn, Sujin, et al.
Publicado: (2017)

Pulmonary-Affinity Paclitaxel Polymer Micelles in Response to Biological Functions of Ambroxol Enhance Therapeutic Effect on Lung Cancer
por: He, Wenxiu, et al.
Publicado: (2020)

A Rapid, Stability Indicating RP-UPLC Method for Simultaneous Determination of Ambroxol Hydrochloride, Cetirizine Hydrochloride and Antimicrobial Preservatives in Liquid Pharmaceutical Formulation
por: Trivedi, Rakshit Kanubhai, et al.
Publicado: (2011)

Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
por: Narita, Aya, et al.
Publicado: (2016)

Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons
por: Magalhaes, J., et al.
Publicado: (2018)

Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
por: Migdalska‐Richards, Anna, et al.
Publicado: (2017)

Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole
por: Li, Xiuyun, et al.
Publicado: (2017)

Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
por: Heber, Sebastian, et al.
Publicado: (2022)

Mechanistic Insight into the Mode of Action of Acid β-Glucosidase Enhancer Ambroxol
por: Pantoom, Supansa, et al.
Publicado: (2022)

Community pharmacy customer segmentation based on factors influencing their selection of pharmacy and over-the-counter medicines
por: Kevrekidis, Dimitrios Phaedon, et al.
Publicado: (2018)

Biodegradable Chitosan-Based Ambroxol Hydrochloride Microspheres: Effect of Cross-Linking Agents
por: Gangurde, HH, et al.
Publicado: (2011)

Uso de ambroxol vs ventilación con enfermedad de membrana hialina
por: Ramírez Pérez, Manuel Adhiel
Publicado: (1999)

Isolation, Identification, and Characterization of One Degradation Product in Ambroxol by HPLC-Hyphenated Techniques
por: Thummala, Veera Raghava Raju, et al.
Publicado: (2014)

Ambroxol hydrochloride in the management of idiopathic pulmonary fibrosis: Clinical trials are the need of the hour
por: Gupta, P. R.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mkrq4op3pqdjfvvg6qgh7h1lgg